These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 3669760

  • 1. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG, Ratain MJ, Golomb HM, Bitter MA, Groves C, Vardiman JW.
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
    Flandrin G, Sigaux F, Castaigne S, Degos L.
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M.
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [Abstract] [Full Text] [Related]

  • 10. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
    Pangalis GA, Kittas C, Viniou N, Kokkinou S, Variamis H, Paizis P, Melanthiou F, Fessas P.
    Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
    [Abstract] [Full Text] [Related]

  • 11. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF, Estey EH, Keating MJ, Kurzrock R.
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA, Jacobs AD, Golde DW.
    Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
    [Abstract] [Full Text] [Related]

  • 14. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V, Fehr J, Sauter C, Ottino J.
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon.
    Naeim F, Jacobs AD.
    Hum Pathol; 1985 Dec; 16(12):1200-5. PubMed ID: 4065882
    [Abstract] [Full Text] [Related]

  • 17. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR, Lepe-Zuniga JL, Gutterman JU.
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M, Rolović Z, Vuković S, Elezović I, Tomić D.
    Srp Arh Celok Lek; 1990 Apr; 118(7-8):277-84. PubMed ID: 2097776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.